Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPENDO.00239.2006PMID 16940471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.

  2006influential reference
• Peroxisome Proliferator-activated Receptor-γ Co-activator 1α-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency*

  2005cited by this paper
• Reversible PEGylation of peptide YY3‐36 prolongs its inhibition of food intake in mice

  2005cited by this paper
• Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss.

  2005cited by this paper
• Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.

  2005cited by this paper
• Metabolic syndrome: a clinical and molecular perspective.

  2005cited by this paper
• Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes.

  2005cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.

  2004cited by this paper
• Management of the metabolic syndrome.

  2004cited by this paper
• Obesity, insulin resistance, and cardiovascular disease.

  2004cited by this paper
• The metabolic syndrome: an emerging risk state for cardiovascular disease

  2004cited by this paper
• Effects of PYY[3–36] in rodent models of diabetes and obesity

  2004cited by this paper
• Metabolic syndrome.

  2004cited by this paper
• PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.

  2004cited by this paper
• The metabolic syndrome.

  2004cited by this paper
• Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes.

  2004cited by this paper
• Role of fat amount and type in ameliorating diet‐induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro‐opiomelanocortin mRNA expression

  2004cited by this paper
• The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure.

  2004cited by this paper
• Diagnosing and treating metabolic syndrome.

  2004cited by this paper
• Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

  2004cited by this paper
• Inhibition of food intake in obese subjects by peptide YY3-36.

  2003cited by this paper
• CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300143-JLR200

  2003cited by this paper
• Altered levels of POMC, AgRP and MC4-R mRNA expression in the hypothalamus and other parts of the limbic system of mice prone or resistant to chronic high-energy diet-induced obesity.

  2003cited by this paper
• Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

  2003cited by this paper
• Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.

  2003cited by this paper
• Food fails to suppress ghrelin levels in obese humans.

  2002cited by this paper
• Gut hormone PYY3-36 physiologically inhibits food intake

  2002cited by this paper
• Chronic application of MTII in a rat model of obesity results in sustained weight loss.

  2002cited by this paper
• Central melanocortin receptors regulate insulin action.

  2001cited by this paper
• Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.

  2001cited by this paper
• Food intake inhibition and reduction in body weight gain in rats treated with GI264879A, a non-selective NPY-Y1 receptor antagonist.

  2001cited by this paper
• In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake.

  2001cited by this paper
• Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat.

  2000cited by this paper
• Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain.

  2000cited by this paper
• Insulin resistance and cardiovascular disease.

  2000cited by this paper
• Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.

  1999cited by this paper
• Stimulatory Actions of Insulin-Like Growth Factor-I and Transforming Growth Factor-α on Intestinal Neurotensin and Peptide YY1.

  1999cited by this paper
• Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.

  1999cited by this paper
• Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY.

  1999cited by this paper
• Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1‐selective antagonist BIBP3226

  1998cited by this paper
• Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.

  1998cited by this paper
• Intracerebroventricular Neuropeptide Y Acutely Influences Glucose Metabolism and Insulin Sensitivity in the Rat

  1997cited by this paper
• Attenuated GLP-1 secretion in obesity: cause or consequence?

  1996cited by this paper
• Skeletal muscle utilization of free fatty acids in women with visceral obesity.

  1995cited by this paper
• Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus.

  1995cited by this paper
• Thermoregulatory effect of intracerebral injections of neuropeptide Y in rats at different environmental temperatures.

  1994cited by this paper
• Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.

  1994cited by this paper
• Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.

  1993cited by this paper
• Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging.

  1992cited by this paper
• Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.

  1990cited by this paper
• Metabolic effects of neuropeptide Y injections into the paraventricular nucleus of the hypothalamus.

  1990cited by this paper
• Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss.

  1989cited by this paper

• The role of PYY in improving insulin resistance.

  2026cites this paper
• Gut Hormones and Inflammatory Bowel Disease

  2025cites this paper
• Advancing obesity treatments through innovations in the design and manufacturing of therapeutic peptides

  2025cites this paper
• Variant screening of PYY3-36 leads to potent long-acting PYY analogs with superior Y2 receptor selectivity.

  2025cites this paper
• Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide

  2025cites this paper
• GLP-1 and PYY for the treatment of obesity: a pilot study on the use of agonists and antagonists in diet-induced rats

  2024cites this paper
• Silymarin supplementation could improve the effect of exercise training on high-fat diet-induced metabolic disorders

  2024cites this paper
• The Impact of Gastrointestinal Hormones on Human Adipose Tissue Function

  2024cites this paper
• Reductions of food intake and body weight in diet-induced obese rats following chronic treatment with a monomeric peptide multiagonist.

  2024cites this paper
• The association between gut hormones and diet‐induced metabolic flexibility in metabolically healthy adults

  2022cites this paper
• A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss

  2022cites this paper
• Exendin(9‐39)NH2: Recommendations for clinical use based on a systematic literature review

  2021cites this paper
• Clamping Cortisol and Testosterone Mitigates the Development of Insulin Resistance during Sleep Restriction in Men.

  2021cites this paper
• Role of Enteroendocrine Hormones in Appetite and Glycemia.

  2021cites this paper
• Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis

  2021cites this paper
• Does PYY mediate resolution of diabetes following bariatric surgery?

  2019cites this paper
• The effect of peptide tyrosine tyrosine (PYY3–36), a selective Y2 receptor agonist on streptozotocin-induced diabetes in albino rats

  2019cites this paper
• Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?

  2018cites this paper
• Weighted Gene Co‐Expression Network Analysis Identifies Gender Specific Modules and Hub Genes Related to Metabolism and Inflammation in Response to an Acute Lipid Challenge

  2018cites this paper
• Dietary steamed wheat bran increases postprandial fat oxidation in association with a reduced blood glucose-dependent insulinotropic polypeptide response in mice

  2017cites this paper
• Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial

  2017cites this paper
• A new proposed mechanism of action for gastric bypass surgery: Air hypothesis.

  2017cites this paper
• Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men.

  2016cites this paper
• Serum Adipsin Levels throughout Normal Pregnancy and Preeclampsia

  2016cites this paper
• Acute effects of exercise on appetite, appetite regulatory hormones and energy intake in lean and overweight men and women

  2016cites this paper
• Effekt starker Gewichtsreduktion (Diät vs Schlauchmagen) auf Inflammation und Glukosemetabolismus bei adipösen Patienten mit Typ 2 Diabetes

  2015cites this paper
• Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes

  2015cites this paper
• Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model

  2014cites this paper
• Omega-3 Fatty Acids and FFAR4

  2014cites this paper
• GPR120 agonism as a countermeasure against metabolic diseases.

  2014cites this paper
• Interactions between the gut, the brain and brown adipose tissue function.

  2014cites this paper
• Administration of the Y2 Receptor Agonist PYY3-36 in Mice Induces Multiple Behavioral Changes Relevant to Schizophrenia

  2013cites this paper
• Chapter 157 – PYY

  2013cites this paper
• Effects of Gastrogastric Fistula Repair on Weight Loss and Gut Hormone Levels

  2013cites this paper
• Duodenal–Jejunal Bypass Surgery Up-Regulates the Expression of the Hepatic Insulin Signaling Proteins and the Key Regulatory Enzymes of Intestinal Gluconeogenesis in Diabetic Goto–Kakizaki Rats

  2013cites this paper
• Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats.

  2013cites this paper
• Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion[S]

  2013cites this paper
• Acute effects of exercise on appetite, food intake and circulating concentrations of gastrointestinal hormones

  2013cites this paper
• Mesoporous Silicon (PSi) for Sustained Peptide Delivery: Effect of PSi Microparticle Surface Chemistry on Peptide YY3-36 Release

  2012cites this paper
• Type 2 Diabetes Control in a Nonobese Rat Model Using Sleeve Gastrectomy with Duodenal–Jejunal Bypass (SGDJB)

  2012cites this paper
• Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.

  2012cites this paper
• Adult-onset PYY overexpression in mice reduces food intake and increases lipogenic capacity.

  2012influential citation
• Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.

  2012cites this paper
• Postpyloric Gastrointestinal Peptides

  2012cites this paper
• NPY modulates PYY function in the regulation of energy balance and glucose homeostasis

  2012cites this paper
• Abnormal plasma peptide YY(3-36) levels in patients with liver cirrhosis.

  2011cites this paper
• A role for metalloendopeptidases in the breakdown of the gut hormone, PYY 3-36.

  2011cites this paper
• First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis

  2011cites this paper
• The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer.

  2011cites this paper
• NPY receptors as potential targets for anti‐obesity drug development

  2011influential citation
• Vertical Sleeve Gastrectomy: Mechanisms for Weight Loss and Lessons for Obesity Therapy

  2011cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2011cites this paper
• Association of adiponectin levels and insulin demand in critically ill patients

  2011cites this paper
• Pulmonary delivery of peptide YY for food intake suppression and reduced body weight gain in rats

  2011cites this paper
• Y2 and Y4 receptor signaling synergistically act on energy expenditure and physical activity.

  2010cites this paper
• High fat diet induced disturbances of energy metabolism

  2010cites this paper
• The role of gut hormones in the regulation of body weight and energy homeostasis.

  2010cites this paper
• Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy

  2010cites this paper
• Effects of albumin‐conjugated PYY on food intake: the respective roles of the circumventricular organs and vagus nerve

  2010cites this paper
• Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal Responses

  2010cites this paper
• Therapeutic potential of gut peptides.

  2010cites this paper
• The role of glycosphingolipids in insulin signaling and lipid metabolism

  2009cites this paper
• Do Incretins Play a Role in the Remission of Type 2 Diabetes after Gastric Bypass Surgery: What are the Evidence?

  2009influential citation
• Treatment of genetically obese (ob/ob) mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)- deoxynojirimycin (AMP-DNM) increases fat oxidation and decreases food intake

  2009cites this paper
• Treatment of genetically obese mice with the iminosugar AMP-DNM increases fat oxidation and decreases food intake

  2009cites this paper
• Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.

  2009cites this paper
• The role of peptide YY in appetite regulation and obesity

  2009cites this paper
• cAMP-dependent Signaling Regulates the Adipogenic Effect of n-6 Polyunsaturated Fatty Acids*

  2008cites this paper
• Peptide YY: food for thought.

  2008cites this paper
• Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.

  2008cites this paper
• Energy metabolism and body composition following recovery from anorexia nervosa

  2008cites this paper
• Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women.

  2008cites this paper
• Peptide YY

  2008cites this paper
• Gut–brain axis

  2008cites this paper
• Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.

  2008cites this paper
• Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?

  2008cites this paper
• Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.

  2007cites this paper
• Bibliography. Current world literature. Diabetes and the endocrine pancreas II.

  2007cites this paper
• Hypothalamic galanin and plasma leptin and ghrelin in the maintenance of energy intake in the Brattleboro rat.

  2007cites this paper
• Insulin sensitivity : modulation by neuropeptides and hormones

  2006cites this paper